Otros idiomas Lipum AB

Acciones

LIPUM

SE0015660899

Diferido Nasdaq Stockholm Otros sitios de cotización 09:37:57 03/06/2024			Varia. Cinco días.	Varia. 1 de enero.
6,6 ^SEK	-3,65 %		+4,76 %	+1,23 %

06/05	Lipum obtiene un préstamo de 20 millones de coronas suecas de Flerie Invest	MT
02/04	Lipum refuerza su protección del fármaco candidato Sol-116 mediante una solicitud de patente para el cáncer provocado por la inflamación	CI

Otros idiomas

Desbloquee todas las noticias sobre todas las empresas: ¡No vuelvas a perderse una oportunidad de inversión rentable!

Inscripción 100% Gratuita

Lipum Obtains SEK20 Million Loan from Flerie Invest	06/05
Lipum Strengthens Its Protection of the Drug Candidate Sol-116 Through A Patent Application for Inflammation-Driven Cancer	02/04
Flerie Invest AB cancelled the acquisition of remaining 67.99% stake in Lipum AB (OM:LIPUM).	20/03
Lipum Recommends Shareholders to Not Accept Mandatory Cash Offer	20/03
Lipum AB Reports First Patient Included in the Ongoing Phase I Clinical Study with SOL-116	19/03
Lipum AB Reports Earnings Results for the Full Year Ended December 31, 2023	29/02
Lipum AB Advances SOL-116 into Phase 2	29/02
Lipum AB Reports Positive Interim Results from Clinical Phase 1 Study Showing that SOL-116 Reduces Plasma BSSL Levels in Healthy Subjects	29/01
Lipum AB Announces Nomination Committee Appointments	18/12
Biopharmaceutical Company Lipum Names New CEO	15/11
Lipum AB Appoints Ola Sandborgh as Chief Executive Officer, Effective from December 1, 2023	09/11
Lipum AB Appoints Karin Franck-Larsson as CMO	01/11
Lipum AB Announces Final Stages of the Clinical Phase I Study with SOL-116	01/11
Lipum AB Reports Earnings Results for the Nine Months Ended September 30, 2023	31/10/23
Lipum AB Reports Earnings Results for the Half Year Ended June 30, 2023	31/08/23
Lipum Signs Research Collaboration with Sweden's Karolinska Institute	08/08/23
Lipum AB Enters Collaboration with the Karolinska Institute, Division of Rheumatology At the Department of Medicine in Sweden	08/08/23
Lipum Elects Carl-Johan Spak as New Board Member	23/05/23
Lipum AB Reports Earnings Results for the First Quarter Ended March 31, 2023	25/04/23
Lipum AB Auditor Raises 'Going Concern' Doubt	19/04/23

No hay resultados para esta búsqueda

Todas Recomendaciones analistas Eventos destacados Insiders Transcripts Comunicados Publs. oficiales Otros idiomas Ideas de trading Artículos de MarketScreener Estrategias MarketScreener

Otros idiomas Lipum AB

Acciones

LIPUM

SE0015660899

Otros idiomas

Filtros